# Independent Data-Use Governance Dossier for Supplied Breast-Cancer Dataset Candidates

**Status:** Documentation-only governance dossier. It turns the outstanding data-use requirements into explicit gates after the public-metadata review. It does not authorize access to any candidate, download a dataset, inspect an asset, or begin data processing, modeling, training, inference, metrics, update, submission, aggregation, deployment, or runtime work.

## 1. Nontechnical requirements and explicit non-goals

The potential research value is limited to enabling a future study to consider public dataset candidates through accountable data governance rather than treating public availability as blanket permission. The stakeholders include the candidate researcher, the supervising academic authority, relevant institutional research or ethics functions, data-protection and legal reviewers where applicable, the original rights holders or source custodians, and any publication or examination authority.

The data-sovereignty posture is restrictive: an asset must not cross into the project until a separate authority confirms a specific permitted purpose and safeguards. Measurable acceptance for this dossier is an explicit, evidence-backed decision for each gate—not an assumption based on a listing, a license label, or a past project. Its explicit non-goals are data access, download, data inspection, de-identification assessment, annotation review, training, model development, performance evaluation, clinical interpretation, hospital use, deployment, and runtime testing.

## 2. Technical requirements and trust boundary

The existing documentation site and Hospital Node Agent remain outside the future data boundary. A future approved research environment must designate ownership, identity, permitted workspaces, access controls, retention controls, and disposal conditions before a dataset asset is received. The present source-only Agent chain may not be repurposed as an intake, storage, inspection, classifier, or transfer mechanism.

| Requirement | Required evidence before any data access | Current status |
|---|---|---|
| Named research authority | Written authorization for a defined study purpose and responsible roles. | Unassigned. |
| Primary-source rights chain | Original source and all republication/transformation conditions are documented. | Unresolved. |
| License-use analysis | Permitted access, research, derivative, sharing, reporting, and publication uses are confirmed. | Unresolved. |
| Ethics and data protection | Applicable review, consent, de-identification, security, retention, and access requirements are confirmed. | Unassigned. |
| Isolated technical environment | A separate approved environment and handling design exist. | Unassigned. |
| Prespecified analysis protocol | Model, split, metric, reporting, bias, reproducibility, and stop conditions are approved before access. | Unassigned. |

## 3. Data and schema policy

No candidate dataset asset, row, image, label, annotation, identifier, file name, archive, path, manifest, checksum, raw metadata export, or access credential is stored in this dossier or the source-only project. The only current facts are scalar candidate-level gate states: `ineligible_pending_primary_source_rights_and_governance`, `ineligible_license_unresolved`, and `ineligible_pending_primary_source_chain_and_governance`.

Any future data-use record must be additive, minimally sufficient, immutable, and redacted. It must record decision authority, policy version, allowed purpose, review date, gate outcome, retention class, and escalation path, but must never expose raw data, access locators, credentials, patients, identifiers, or sensitive metadata in public documentation.

## 4. Governance workflow and failure closure

The future workflow begins with a written study question and a named accountable authority. It then verifies the primary-source and license chain, obtains relevant institutional and data-protection decisions, approves a data-management plan and isolated environment, and accepts a prespecified analysis plan. Only after every gate is positively evidenced may the responsible authority decide whether any separate data-use activity is permissible.

| Workflow state | Entry requirement | Terminal closure condition |
|---|---|---|
| `unassigned` | No verified authority or review record. | Remains closed to data access. |
| `under_independent_review` | Named authority and bounded review package exist. | Closes if any required evidence is missing, conflicting, or expired. |
| `eligible_for_separate_decision` | Every listed gate is positively evidenced. | Does not itself authorize access; it permits only a new, separately recorded decision. |
| `ineligible` | A required gate is unresolved, denied, or insufficient. | No download, inspection, processing, or model action occurs. |

No automatic retry, substitution, fallback dataset, silent scope expansion, or derived claim is permitted. A license ambiguity, source-chain gap, data-protection uncertainty, or protocol deficiency closes the candidate at the `ineligible` state until independently resolved.

## 5. Architecture and dependency direction

This dossier is a governance document, not a data connector. Its architecture is intentionally limited to public documentation, an independent review authority, a future approved environment, and a distinct future research protocol. There is no module, port, adapter, client, storage interface, dataset parser, model interface, trainer, evaluator, metric engine, or orchestration root in the current project for data use.

The following dependencies remain forbidden in the present branch: direct dataset download, third-party dataset API, account credential, cloud store, filesystem dataset reader, image parser, training framework, model artifact handler, inference engine, metric library, update envelope, submission path, aggregation worker, hospital system, clinical workflow, user-facing upload path, and runtime service.

## 6. Engineering standards and observability

Any future technical implementation requires a new dossier with source-specific rights evidence, a minimization design, strict input validation, finite state transitions, redacted logs, secret isolation, bounded resource policy, reproducible test fixtures that contain no real sensitive material, and a separate threat and privacy assessment. It must not treat a license label as a substitute for a rights analysis or a model metric as a substitute for clinical evidence.

The present observability posture is documentation-only. It records only candidate-level governance state and does not retain assets, raw page exports, download history, user identities, access attempts, credentials, data characteristics, model facts, or runtime telemetry.

## 7. Readout taxonomy

The sole allowed present readout is a scalar governance disposition. It has no request body, response body, data sample, file reference, or capability projection.

| Field | Allowed values | Meaning |
|---|---|---|
| `reviewScope` | `public_metadata_only` | The underlying asset has not been accessed. |
| `dataUseEligibility` | `ineligible` | A data-use decision has not been reached. |
| `nextAuthority` | `independent_governance_required` | The next actor must be an accountable reviewer, not the source-only Agent. |
| `prohibitedActions` | `download`, `open`, `copy`, `process`, `store`, `transfer`, `train`, `infer`, `evaluate` | Actions excluded from the present branch. |

## 8. Test and proof boundaries

This dossier requires no model, data, or runtime test. Its evidence is the completed public-metadata review and the explicit unresolved-gate matrix. A future technical proof, if ever independently authorized, must be scoped in a new plan and must distinguish design, local quality, deployment, and runtime evidence. No such proof is planned, enabled, or implied here.

## 9. Handoff, stop conditions, and current outcome

The dossier may be handed to a supervisor, institutional review function, legal or data-protection reviewer, and original-source rights holder as a checklist for a future decision. The responsible reviewer must either provide explicit evidence for every gate or retain the candidate as ineligible. The source-only project must stop if an action would retrieve or expose a dataset asset, require an account, credential, provider, storage or transport capability, initiate modeling, or create a clinical, privacy, or runtime claim.

> **Current outcome:** No supplied candidate is authorized for data use in this branch. No dataset asset has been downloaded, opened, copied, or processed. The only present evidence is public page metadata and the independent-governance requirements it leaves unresolved.

## References

[1] [Kaggle breast-cancer dataset public metadata and eligibility review](./KAGGLE_BREAST_CANCER_DATASET_PUBLIC_METADATA_AND_ELIGIBILITY_REVIEW.md)

[2] [Synthetic patient-data marker rejection chain completion audit](./SYNTHETIC_PATIENT_DATA_MARKER_REJECTION_CHAIN_COMPLETION_AUDIT.md)
